Encompass Health EBITDA Margin 2010-2024 | EHC

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Encompass Health (EHC) over the last 10 years. The current EBITDA margin for Encompass Health as of September 30, 2024 is .
Encompass Health EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $5.22B $1.13B 21.57%
2024-06-30 $5.07B $1.08B 21.38%
2024-03-31 $4.96B $1.05B 21.22%
2023-12-31 $4.80B $1.02B 21.18%
2023-09-30 $4.69B $1.00B 21.30%
2023-06-30 $4.57B $0.96B 21.05%
2023-03-31 $4.45B $0.92B 20.58%
2022-12-31 $4.35B $0.88B 20.30%
2022-09-30 $3.70B $0.76B 20.58%
2022-06-30 $3.62B $0.75B 20.83%
2022-03-31 $3.84B $0.83B 21.46%
2021-12-31 $4.02B $0.89B 22.04%
2021-09-30 $3.67B $0.86B 23.41%
2021-06-30 $3.83B $0.89B 23.20%
2021-03-31 $3.61B $0.77B 21.22%
2020-12-31 $3.57B $0.74B 20.64%
2020-09-30 $4.61B $0.85B 18.44%
2020-06-30 $4.60B $0.84B 18.34%
2020-03-31 $4.66B $0.91B 19.45%
2019-12-31 $4.61B $0.91B 19.72%
2019-09-30 $4.52B $0.86B 18.99%
2019-06-30 $4.42B $0.86B 19.33%
2019-03-31 $4.36B $0.86B 19.70%
2018-12-31 $4.28B $0.83B 19.47%
2018-09-30 $4.19B $0.88B 20.97%
2018-06-30 $4.11B $0.86B 21.02%
2018-03-31 $4.00B $0.84B 20.96%
2017-12-31 $3.91B $0.83B 21.26%
2017-09-30 $3.84B $0.84B 21.84%
2017-06-30 $3.77B $0.84B 22.19%
2017-03-31 $3.71B $0.84B 22.69%
2016-12-31 $3.64B $0.84B 22.95%
2016-09-30 $3.58B $0.80B 22.41%
2016-06-30 $3.43B $0.77B 22.30%
2016-03-31 $3.28B $0.73B 22.23%
2015-12-31 $3.12B $0.68B 21.76%
2015-09-30 $2.86B $0.63B 22.04%
2015-06-30 $2.68B $0.60B 22.43%
2015-03-31 $2.52B $0.58B 23.17%
2014-12-31 $2.38B $0.58B 24.21%
2014-09-30 $2.34B $0.59B 25.13%
2014-06-30 $2.30B $0.60B 26.10%
2014-03-31 $2.27B $0.58B 25.68%
2013-12-31 $2.25B $0.58B 25.90%
2013-09-30 $2.23B $0.56B 25.30%
2013-06-30 $2.20B $0.53B 24.24%
2013-03-31 $2.17B $0.52B 24.03%
2012-12-31 $2.14B $0.50B 23.56%
2012-09-30 $2.09B $0.49B 23.29%
2012-06-30 $2.06B $0.48B 23.07%
2012-03-31 $2.04B $0.47B 23.17%
2011-12-31 $2.01B $0.47B 23.18%
2011-09-30 $1.95B $0.45B 23.12%
2011-06-30 $1.91B $0.44B 22.84%
2011-03-31 $1.87B $0.41B 22.02%
2010-12-31 $1.86B $0.40B 21.49%
2010-09-30 $1.78B $0.38B 21.30%
2010-06-30 $1.79B $0.37B 20.64%
2010-03-31 $1.80B $0.33B 18.25%
2009-12-31 $1.79B $0.33B 18.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.984B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00